Login to Your Account

GSK Partnership 'Catapults' Cell Therapy Projects in UK

By Nuala Moran
Staff Writer

Wednesday, May 29, 2013
LONDON – The publicly funded UK center set up to accelerate the commercialization of cell therapies has signed its first deal with big pharma, agreeing to work with GlaxoSmithKline plc on a range of research projects and technical and regulatory strategies for getting products to market.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription